课题基金 / 基金详情

Mouse Pathobiology: Models of Human Disease

Mouse Pathobiology: Models of Human Disease
小鼠病理学:人类疾病模型
批准号:
8847420
负责人:
Michael J Oglesbee
金额:
$35.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-07-01 至 2016-03-31

项目摘要

项目成果

Michael J Oglesbee的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This institutional T-32 training grant (RR07073) proposal seeks funds to continue an outstanding environment for veterinarians (DVM or VMD) and DVM/PhDs to acquire specific research and conceptual skills to effectively utilize mouse models of human disease. Significant need exists for skilled scientists trained in modern translational research methods to apply advances in medicine to improve human health. The training program has enrolled 20 DVMs into the program since 2002 through outstanding recruitment and leverage of resources. Of the 20 trainees supported over the first 9 years of the program, 8 were awarded NIH K, TL1, or F Awards and 13 have matriculated and are employed in biomedical or academic positions and the remaining are on track to complete their training. All veterinarians recruited into the program have outstanding academic backgrounds and established records of research experiences. New training faculty and courses compliment experienced mentors who train veterinarian scientists in state-of-the-art molecular and cellular techniques to systematically evaluate the pathobiology of experimental mouse models of human disease important to public health. The training program is coordinated through The Ohio State University (OSU), College of Veterinary Medicine, Graduate Program in Comparative and Veterinary Medicine; an integral component of the most comprehensive health sciences center in America. The Specific Aims of the training program include: 1) trainees will gain knowledge and skills to fully understand and evaluate pathophysiologic alterations of murine models of human disease through both didactic coursework and applied training in pathology and molecular biology; 2) trainees will interact with our multidisciplinary faculty to identify the rane of research problems that use murine and other rodent models; 3) trainees will acquaint themselves with the ongoing basic and clinical research studies in the laboratories and clinical sites of the participating faculty, and select a research problem that utilizes a murine or rodent model for endpoint evaluation; and 4) following the selection of a preceptor and research problem, trainees will participate in the design and performance of experiments, as well as analysis and presentation of data. These specific aims support the overall goal of the T-32 Program to support trainees to acquire a broad background in molecular biology, genetics, pathology, laboratory animal medicine, and research design methodology. Training faculty represent an experienced group of basic and clinical scientists with strong training records from collaborative programs in multiple departments at OSU and Nationwide Children's Hospital. As a result of this training program, trainees will gain a comprehensive understanding of hypothesis-based research and gain knowledge and skills required to fulfill national needs in the development of skilled scientists in mouse pathobiology relevant to human health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
FACILITIES IMPROVEMENT FOR INFECTIOUS DISEASE RESEARCH
  • 批准号:
    6826709
  • 项目类别:
  • 资助金额:
    $392.1万
  • 财政年份:
    2009
  • 负责人:
    Michael J Oglesbee
  • 依托单位:
Short term training for veterinary students
  • 批准号:
    10163936
  • 项目类别:
  • 资助金额:
    $8.11万
  • 财政年份:
    2009
  • 负责人:
    Michael J Oglesbee
  • 依托单位:
Short Trem Research Training for Veterinary Students
  • 批准号:
    8258239
  • 项目类别:
  • 资助金额:
    $7.08万
  • 财政年份:
    2009
  • 负责人:
    Michael J Oglesbee
  • 依托单位:
Short Trem Research Training for Veterinary Students
  • 批准号:
    8433214
  • 项目类别:
  • 资助金额:
    $7.08万
  • 财政年份:
    2009
  • 负责人:
    Michael J Oglesbee
  • 依托单位:
国内基金
海外基金
奥沙利铂通过p53/PIAS3/MUS81轴增强胃癌免疫治疗效果的机制研究
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
  • 依托单位:
MUS81通过介导STING/NFKB通路激活调控巨噬细胞炎症及肺损伤的作用及机制研究
  • 批准号:
    82300102
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2023
  • 负责人:
    李淼
  • 依托单位:
DNA损伤修复蛋白MUS81-SLX4互作对维持基因组稳定性的机制研究
  • 批准号:
    22ZR1432700
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2022
  • 负责人:
    万兵兵
  • 依托单位:
ATR抑制剂通过MUS81蛋白SUMO化增强胃癌免疫治疗效果的分子机制研究
  • 批准号:
    --
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    30万元
  • 批准年份:
    2022
  • 负责人:
    沈倩
  • 依托单位: